Angiotensin-converting enzyme inhibitor: Difference between revisions
Jump to navigation
Jump to search
imported>Bruce M. Tindall m ((Insignificant change to force re-alphabetization in Live Articles list)) |
imported>Robert Badgett mNo edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
'''Angiotensin-converting enzyme inhibitors''' (commonly '''ACE inhibitors''') are a "class of drugs whose main indications are the treatment of [[hypertension]] and [[heart failure]]. They exert their hemodynamic effect mainly by inhibiting the renin- | '''Angiotensin-converting enzyme inhibitors''' (commonly '''ACE inhibitors''') are a "class of drugs whose main indications are the treatment of [[hypertension]] and [[heart failure]]. They exert their hemodynamic effect mainly by inhibiting the [[renin-angiotensin system]]. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.<ref>{{MeSH|Angiotensin-converting enzyme inhibitors}}</ref> | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 23:40, 14 June 2008
Angiotensin-converting enzyme inhibitors (commonly ACE inhibitors) are a "class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.[1]
References
- ↑ Anonymous (2024), Angiotensin-converting enzyme inhibitors (English). Medical Subject Headings. U.S. National Library of Medicine.